FDA Inspection
American Regent, Inc.American Regent, Inc. – FDA Inspection, Jan 29, 2026
Record Details
This FDA Inspection record concerns American Regent, Inc., with an inspection on January 29, 2026, issued by the Cincinnati District Office, covering human drugs.
View Company Profile
ID · 8aeb4515-d899-49f3-81f9-a4da3c8efe40
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1300772
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
4- 21 CFR 211.113(b)Procedures for sterile drug products
- 21 CFR 211.192Investigations of discrepancies, failures
- 21 CFR 211.22(d)Procedures not in writing, fully followed
- 21 CFR 211.84(e)Rejecting When Specifications Not Met
Full citation text and observation details available on the Dashboard.
Other FDA inspections of American Regent, Inc.
5| Date | Classification | Office | Project area |
|---|---|---|---|
| September 30, 2022 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 6, 2018 | Not classified | Cincinnati District Office | |
| October 28, 2016 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 5, 2016 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 19, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for American Regent, Inc.
- FDA Inspection 1181474 - 2022-09-30
- FDA Inspection 1075820 - 2018-11-06
- FDA Inspection 993760 - 2016-10-28
- FDA Inspection 971841 - 2016-05-05
- FDA Inspection 918587 - 2015-03-19
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.